Huapont Life SciencesLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Hai Zhang

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	5.4yrs
CEO ownership	n/a
Management average tenure	10.3yrs
Board average tenure	8.6yrs

Recent management updates

Recent updates

CEO

Hai Zhang (42 yo)

5.4yrs

Tenure

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jian Wang	Chief Financial Officer	10.3yrs	CN¥482.70k	0.0063% CN¥ 573.4k
Yun Hui Peng	Secretary of the Board and Director	22.6yrs	CN¥847.00k	0.076% CN¥ 6.9m
Hai Zhang	GM & Director	5.4yrs	no data	no data

10.3yrs

Average Tenure

47yo

Average Age

Experienced Management: 002004's management team is seasoned and experienced (10.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Yun Hui Peng	Secretary of the Board and Director	16.6yrs	CN¥847.00k	0.076% CN¥ 6.9m
Hai Zhang	GM & Director	5.4yrs	no data	no data
Songshan Zhang	Chairman	22.6yrs	CN¥1.85m	8.7% CN¥ 790.2m
Rong Wang	Director	12.2yrs	CN¥1.89m	0.55% CN¥ 49.6m
Zhonghai Liu	Independent Director	2.7yrs	CN¥142.90k	no data
Qiang Bian	Shareholder Supervisor	12.6yrs	CN¥96.00k	no data
Wen Wang	Employee Representative to the Board for Supervisors	8.6yrs	no data	no data
Ming Li	Independent Director	no data	CN¥142.90k	no data
Shuang Liang	Independent Director	5.8yrs	no data	no data
Zhengjun Wang	Chairman of the Supervisory Board	2.7yrs	no data	0.010% CN¥ 931.5k

8.6yrs

Average Tenure

55yo

Average Age

Experienced Board: 002004's board of directors are considered experienced (8.6 years average tenure).

Huapont Life SciencesLtd Management

Management criteria checks 2/4

Key information

Recent management updates

Huapont Life Sciences Co.,Ltd, Annual General Meeting, May 23, 2024

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Huapont Life Sciences Co., Ltd., Annual General Meeting, Apr 12, 2022

Recent updates

Huapont Life Sciences Co.,Ltd, Annual General Meeting, May 23, 2024

First quarter 2024 earnings released: EPS: CN¥0.079 (vs CN¥0.09 in 1Q 2023)

Huapont Life Sciences Co.,Ltd to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment improves as stock rises 15%

Huapont Life Sciences Co.,Ltd (SZSE:002004) announces an Equity Buyback for CNY 30 million worth of its shares.

Less than half of directors are independent

Huapont Life Sciences Co.,Ltd(SZSE:002004) dropped from Shenzhen Stock Exchange Component Index

Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.079 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.20 in 2Q 2022)

Huapont Life Sciences Co.,Ltd Announces Final Dividend on Share A for 2022, Payable on June 15, 2023

Huapont Life Sciences Co.,Ltd Approves Final Cash Dividend Per 10 Shares for 2022

First quarter 2023 earnings released: EPS: CN¥0.09 (vs CN¥0.085 in 1Q 2022)

Now 21% undervalued after recent price drop

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.079 (vs CN¥0.08 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.12 in 2Q 2021)

Huapont Life Sciences Co., Ltd. Announces Dividend on A Shares for the Year 2021, Payable on June 2, 2022

First quarter 2022 earnings released: EPS: CN¥0.085 (vs CN¥0.06 in 1Q 2021)

Less than half of directors are independent

Huapont Life Sciences Co., Ltd. Approves Profit Distribution for 2021

Huapont Life Sciences Co., Ltd., Annual General Meeting, Apr 12, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.10 in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Zhejiang Xinan Chemical Industrial Group Co.,Ltd (SHSE:600596) entered into an agreement to acquire 12.31% stake in Nutrichem Company Limited from Huapont Life Sciences Co., Ltd. (SZSE:002004) for approximately CNY 800 million.

Second quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.12 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.06 (vs CN¥0.04 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.33 (vs CN¥0.31 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.33 (vs CN¥0.31 in FY 2019)

Huapont Life Sciences Co., Ltd. to Report Fiscal Year 2020 Results on Apr 01, 2021

New 90-day low: CN¥5.02

New 90-day high: CN¥6.06

New 90-day high: CN¥5.71

Third quarter earnings released

New 90-day low: CN¥5.18

Earnings released

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age